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In order to better understand the impact of reduced mitochondrial function for the development of insulin resistance and cellular metabolism,
human myotubes were established from lean, obese, and T2D subjects and exposed to mitochondrial inhibitors, either affecting the electron
transport chain (Antimycin A), the ATP synthase (oligomycin) or respiratory uncoupling (2,4-dinitrophenol). Direct inhibition of the electron
transport chain or the ATP synthase was followed by increased glucose uptake and lactate production, reduced glycogen synthesis, reduced lipid
and glucose oxidation and unchanged lipid uptake. The metabolic phenotype during respiratory uncoupling resembled the above picture, except
for an increase in glucose and palmitate oxidation. Antimycin A and oligomycin treatment induced insulin resistance at the level of glucose and
palmitate uptake in all three study groups while, at the level of glycogen synthesis, insulin resistance was only seen in lean myotubes. Primary
insulin resistance in diabetic myotubes was significantly worsened at the level of glucose and lipid uptake. The present study is the first convincing
data linking functional mitochondrial impairment per se and insulin resistance. Taken together functional mitochondrial impairment could be part
of the pathophysiology of insulin resistance in vivo.
© 2007 Elsevier B.V. All rights reserved.Keywords: Glucose metabolism; Insulin resistance; Lipid metabolism; Metabolic inhibition; Mitochondrial function; Myotube; Skeletal muscle; Type 2 diabetes1. Introduction
Type 2 diabetes (T2D) mellitus is characterized by altera-
tions in both lipid and glucose metabolism, and an increasing
body of evidence suggests an association between insulin
resistance, T2D, and mitochondrial dysfunction. Initial in vivo
studies reported a diminished citrate synthase (CS)/hexokinase
(HK) ratio in diabetic skeletal muscles, showing that the
oxidative/glycolytic ratio correlated with insulin sensitivity [1].
Mitochondrial size and activity were also shown to be reduced
in obese and T2D subjects and to correlate with the degree of
insulin resistance [2]. Stump et al. [3] showed that insulin hasAbbreviations: AA, antimycin A; BSA, bovine serum albumin; DNP, 2,4-
Dinitrophenol; FCS, foetal calf serum; FFA, Free fatty acids; GIR, glucose
infusion rates; OA, oligomycin A; PA, palmitate; TAG, Triacylglycerol; T2D,
Type 2 diabetic/type 2 diabetes
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doi:10.1016/j.bbadis.2007.03.007a direct, stimulatory effect on mitochondrial ATP production
and mRNA transcripts of mitochondrial enzymes in skeletal
muscle of non-diabetic subjects, whereas no change in
mitochondrial ATP production was observed in T2D subjects.
Moreover, recent analyses of gene expression patterns demon-
strated a coordinated reduction in mRNA transcripts of nuclear-
encoded genes involved in mitochondrial oxidative phosphor-
ylation including the catalytic beta-subunit of the ATP synthase
in both prediabetic and T2D subjects [4–6]. Petersen et al. [7]
provided evidence for a possible, inherited defect in mitochon-
drial oxidative phosphorylation in skeletal muscle of insulin-
resistant offspring of T2D patients. This defect was associated
with dysregulation of intracellular fatty acid metabolism. In
myotubes established from T2D patients, lipid oxidation, and
insulin-mediated glucose oxidation and insulin-mediated
increase in citrate synthase activity were reduced. In addition,
palmitate (PA) impaired insulin-mediated glucose oxidation and
insulin-mediated increase in citrate synthase activity in myo-
tubes of obese non-diabetic subjects [8–10]. Taken together,
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be associated with insulin resistance. Whether a direct link
exists between reduced mitochondrial function and insulin
resistance in skeletal muscles, can be questioned. However, our
current knowledge of oxidative enzyme activities in the
tricarboxylic acid cycle, mitochondrial beta-oxidation, and
electron transport chain in relation to insulin resistance and
T2D originates mainly from in vivo studies. Both the
mitochondrial oxidative capacity and insulin resistance of
skeletal muscle are highly influenced by physical activity,
ageing, and fiber type composition rendering it difficult to
clarify whether a direct link exists between mitochondrial
dysfunction and insulin resistance in T2D. Cultured myotubes
offer a unique model to separate the genetic influence on insulin
resistance and T2D from environmental factors [11–13], but
also the impact of single factors on the metabolism on various
genetic backgrounds. In order to better understand the impact of
reduced mitochondrial function for the development of insulin
resistance and cellular metabolism, human myotubes were
established from lean, obese, and T2D subjects exposed to
mitochondrial inhibitors either affecting the electron transport
chain (Antimycin A (AA), Complex III inhibitor), the ATP
synthase (oligomycin (OL), F0–F1 inhibitor) or by respiratory
uncoupling (2,4-dinitrophenol, ionophor) in order to evaluate if
exposure to these inhibitors changes the intermediary metabo-
lism and whether they may induce insulin resistance in exposed
myotubes.
2. Methods
2.1. Human study subjects
Ten lean, ten obese control subjects, and ten obese T2D patients participated in
the study (Table 1), and clinical characteristics have previously been published
[10]. Muscle biopsies were obtained from the vastus lateralis muscle by needle
biopsy under local anesthesia. Diabetic patients were treated with either diet alone
or in combination with sulfonylurea, metformin or insulin withdrawn 1 week
before the study. The patients suffered from no diabetic complications except for
simplex retinopathy. The control subjects had normal glucose tolerance and no
family history of diabetes. All subjects gave written informed consent, and the
local ethics committee of Funen and Vejle County approved the study.Table 1
Clinical characteristics of the study subject
Control, lean Control, obese T2D
n 10 10 10
Age (years) 51±1 49±1 50±1
Weight (kg) 71.6±3.0 105.5±6.4 a 102.2±4.1a
BMI (kg/m2) 24.2±0.5 33.7±1.4a 33.5±1.1a
Fasting plasma glucose (mM) 5.7±0.1 5.7±0.2 10.0±0.7 b
Fasting serum insulin (pM) 24.3±5.7 52.7±5.0a 94.6±10.1b
Glucose infusion rate (mg/min) 383.3±20.4 257.9±28.3a 117.8±18.6b
HbA1c (%) 5.5±0.1 5.4±0.1 7.7±0.5
b
Fasting total cholesterol (mM) 5.29±0.22 5.43±0.41 5.42±0.37
Fasting LDL cholesterol (mM) 2.94±0.22 3.33±0.33 3.20±0.27
Fasting HDL cholesterol (mM) 1.85±0.15 1.48±0.15 1.36±0.03a
Fasting plasma triglyceride (mM) 1.12±0.16 1.35±0.18 1.93±0.40
Data are means±SE.
a Significant different from the lean controls (p<0.05).
b Significant different from the lean and obese controls (p<0.05).2.2. Materials
Dulbecco's modified Eagle's medium, fetal calf serum (FCS), penicillin–
streptomycin–amphotericin B, and trypsin–EDTA were obtained from Invitro-
gen (Invitrogen, Scotland, UK). Ultroser G was purchased from Pall Biosepra
(Cergy-Saint-Christophe, France). Protein assay kit was purchased from BioRad
(Copenhagen, DK). Palmitic acid, L-carnitine, AA, OL, and ECM-gel were
purchased from Sigma Chemical Co. (St. Louis, USA). Bovine serum albumin
(BSA) (essentially FA free), were from Calbiochem (VWR, Roskilde, DK).
Insulin Actrapid was from Novo Nordisk (Bagsvaerd, DK).
2.3. Cell culture
Cell cultures were established as previously described [14,15]. In brief,
muscle tissue was minced, washed, and dissociated for 60 min by three
treatments with 0.05% trypsin-EDTA. The cells harvested were pooled and FCS
was added to stop trypsination. The cells obtained were seeded for up-scaling on
ECM-gel coated dishes after 30 min of preplating. Cell cultures were established
in DMEM medium supplemented with 10% FCS, 50 U/ml penicillin, 50 μg/ml
streptomycin, and 1.25 μg/ml amphotericin B. After 24 h cell debris and non-
adherent cells were removed by change of growth medium to DMEM
supplemented with 2% FCS, 2% Ultroser G, 50 U/ml penicillin, 50 μg/ml
streptomycin, and 1.25 μg/ml amphotericin B. Cells were subcultured twice
before final seeding. At 75% confluence the growth medium was replaced by
basal medium (DMEM supplemented with 2% FCS, 50 U/ml penicillin, 50 μg/
ml streptomycin, 1.25 μg/ml amphotericin B, and 25 pmol/l insulin) in order to
induce differentiation. The cells were cultured in humidified 5% CO2
atmosphere at 37°C, and medium was changed every 2–3 days.
2.4. Experimental design
Human myotubes established from lean, obese, and T2D subjects were
allowed to differentiate under physiological conditions of insulin (25pmol/l) and
glucose (5.5 mmol/l) for 8 days. All myotube cultures were used for analysis day
eight after onset of differentiation. At day eight, myotubes were exposed to four
different protocols: (a) basal medium (5.5 mmol/l Glucose, 25 pmol/l Insulin);
(b) basal medium supplemented with 1.0 μg/ml AA; (c) basal medium
supplemented with 5.0 μg/ml OL; (d) basal medium supplemented with
1.0 mmol/l 2,4-Dinitrophenol, and subsequently basal and insulin-stimulated
glucose uptake, glucose oxidation, glycogen synthesis (GS), lipid uptake and
lipid oxidation were determined. Furthermore, the lactate concentration was
determined in the media after terminating the experiments.
2.5. Mitochondrial inhibition
In order to verify that the inhibitors were inhibiting the mitochondria the O2-
utilisation rate of trypsinated myotubes in suspension were measured with a
Clark-type electrode (Hansatech Instruments DW1) in a water-jacket glass
chamber maintained at 25 °C and equipped with magnetic stirring in DMEM
containing 5.5 mmol/l glucose [10]. Myotube cultures were used for analysis day
eight after onset of differentiation. When the O2-respiration reached the stable
rate, the uncoupled respiration was measured after adding increased concentra-
tions of DNP (1 pM to 1mM). The maximal uncoupled respiration was measured
after adding 0.1 mmol/l DNP (final concentration) without further increase,
thereby immediately (30–60 s) enhancing the respiration rate 2.8 times. In
parallel the effect of AA (1 pg/ml to 1 μg/ml) and OA (5 pg/ml to 5 μg/ml) on the
respiration of myotubes were studied after a steady state respiration was
achieved. Maximal inhibition of the respiration of myotubes was achieved at a
concentration of 0.5 mg/ml and 1.25 mg/ml (final concentration) respective
for AA and OA blocking the respiration rate to 5% and 3% of basal respiration
rate (Data not shown, N=2). Furthermore, the total ATP content in cell extract
was measured with the ATP monitoring reagent (ATPlite from PerkinElmer,
Turku, Finland). Cells were grown and differentiated in 12 well plates, as
described above. At day eight, myotubes were exposed to four different
protocols: (a) basal medium (5.5 mmol/l Glucose, 25 pmol/l Insulin); (b) basal
medium supplemented with 0.01, 0.1 and 1.0 μg/ml AA; (c) basal medium
supplemented with 0.05, 0.5 and 5.0 μg/ml OL; d) basal medium supplemented
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soluble metabolites were extracted with trichloroacetic acid (TCA). TCA
extracts were neutralized in Tris buffer (0.1 mol/l) [14] and ATP determined on a
VICTOR Plate Reader model 1420–050 (PerkinElmer, Turku, Finland). Fig. 1
shows the fractionalATP content inmyotubes exposed to increasing concentrations
of used inhibitor compared to baseline condition. The fractional ATP content
tended to be lowered at the maximal used concentrations investigated i.e. 0.92±
0.03, 0.91±0.05 and 0.90±0.02 (n=3) for AA, OA and DNP respectively. The
inhibitors were used at following final concentrations 5.0 μg/ml OL, 1.0 μg/ml AA
and 1.0 mmol/l DNP in the presented experiments to ensure maximal inhibition
of mitochondrial function and equal fractional ATP content.
2.6. Glucose uptake
Cells were grown and differentiated in 12 well plates, as described above.
Cultures were exposed to DMEM supplemented with 0.24 mmol/l fat free
albumin, 50 U/ml penicillin, 50 μg/ml streptomycin, 1.25 μg/ml amphotericin B,
2-deoxyglucose(DOG)/2-[3H]DOG (0.2 μCi/well), and 25 pmol/l or 1 μmol/l
insulin, respectively, in order to study basal and insulin-mediated glucose uptake
[9]. The reaction was stopped after 4 h by aspirating the reaction mixture and
rapidly rinsing each well four times with PBS at 4°C. Cells were solubilized by
addition of 0.5 ml 0.1 M NaOH. An aliquot of 50 μl was removed for protein
determination. The remaining fluid was placed in a scintillation vial, and
scintillation fluid was added. Glucose transport activity was expressed as moles
of 2-deoxy-glucose taken up per minute per absorbance of total protein or per
mg protein.
2.7. Glycogen synthesis
Cells were grown and differentiated in 12 well plates, as described above.
Cultures were exposed to DMEM supplemented with 0.24 mmol/l fat free
albumin, 50 U/ml penicillin, 50 μg/ml streptomycin, 1.25 μg/ml amphotericin B,
D-[14C(U)]glucose (1.0 μCi/well), and 25 pmol/l or 1 μmol/l insulin,
respectively, in order to study basal and insulin-stimulated GS. The reaction
was stopped after 4 h by aspirating the reaction mixture and rapidly rinsing each
well four times with PBS at 4 °C. Cells were solubilized by adding 0.5 ml 1.0 M
KOH and heated at 70 °C for 20 min. 100 μl saturated Na2SO4, 100 μl 25 mg/ml
glycogen were added to the sample in distilled water (freshly made) and 9 ml
ice-cold absolute ethanol and then left at − 70 °C for 48 h for glycogen
precipitation. The tubes were centrifuged (2000×g, 20 min, 4°C) and theFig. 1. The fractional ATP content in myotubes exposed for increasing concentration
grown and differentiated for 8 days under physiological conditions (5.5 mmol/l gluco
basal medium (5.5 mmol/l Glucose, 25 pmol/l Insulin); (b) basal medium supplemen
0.5 and 5.0 μg/ml OL; (d) basal medium supplemented with 0.01, 0.1 and 1.0 mmo
Methods. This figure shows the fractional ATP content in myotubes exposed to in
inhibitor concentration is expressed as percent of maximal used inhibitor. AA (opensupernatant immediately removed and discarded. The glycogen precipitate was
redissolved in 500 μl distilled water by heating at 70°C for 10 min, 9 ml ice-cold
absolute ethanol were added and then left at − 20 °C for minimum 24 h. Again,
the tubes were centrifuged, the supernatants removed and 500 μl distilled water
were added and the glycogen dissolved. 500 μl were taken out for scintillation
counting [8].
2.8. Glucose oxidation
Cells were cultured on 12.5 cm2 flasks and differentiated, as described
above. Cultures were exposed to DMEM supplemented with 0.24 mmol/l fat
free albumin, 50 U/ml penicillin, 50 μg/ml streptomycin, 1.25 μg/ml
amphotericin B, D-[14C] glucose ( 2.0 μCi/ml), and 25 pmol/l or 1 μmol/l
insulin, respectively, in order to study basal and insulin-mediated glucose
oxidation. Flasks were air-tightened with a rubber stopper. After 4 h, 300 μl
phenyl ethylamine–methanol (1:1, v/v) were added with a syringe to a centre
well containing a folded filter paper. 300 μl 1 M perchloric acid were
subsequently added to the cells through the stopper tops by means of a syringe.
The flasks were placed for a minimum of 1 h at room temperature to trap labeled
CO2. Cell-free flasks (no cell controls) went through the same procedure to
correct for unspecific CO2 trapping.
2.9. Lactate concentration
The lactate content in the collected media during the various incubation
conditions was determined spectrophotometrically in accordance with the
method described by Passonneau et al. [16].
2.10. PA uptake
Cells were cultured in 12 well plates and differentiated, as described above.
Myotubes were exposed to DMEM supplemented with 0.24 mmol/l fat free
albumin (BSA), 0.5 mmol/l L-carnitine, 20 mmol/l HEPES, either [1-14C] oleic
acid (2.0 μCi/ml, 0.6 mM) or [1-14C] palmitic acid (2.0 μCi/ml, 0.6 mM) with
5.5 mmol/l glucose and 25 pmol/l or 1 μmol/l insulin and analyzed, as
previously described in [8]. The reaction was stopped after 4 h by aspirating the
reaction mixture and rapidly rinsing each well four times with PBS at 4 °C. Cells
were solubilized by adding 0.5 ml 0.1 M NaOH. An aliquot of 50 μl was
removed for protein determination [17]. The remaining fluid was placed in a
scintillation vial, and scintillation fluid was added. The incubation media wass of AA, OL and DNP. Human satellite cell cultures were established from lean,
se, 25 pmol/l insulin) and exposed to the following media conditions for 4 h: (a)
ted with 0.01, 0.1 and 1.0 μg/ml AA; (c) basal medium supplemented with 0.05,
l/l 2,4-Dinitrophenol, for 4 h and ATP content was determined as described in
creasing concentrations of used inhibitor compared to baseline condition. The
bars), OL (hatched bars) and DNP (black bars). N=3.
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soluble metabolites (ASM)) [18]. Lipid uptake was determined as the sum of
intracellular lipids and ASM. PA:BSA ratio was 2.5:1. Control and treated
myotubes were exposed for equal amount of fatty acid free BSA.
2.11. PA oxidation
Cells were cultured on 12.5 cm2 flasks and differentiated and exposed, as
described above. Myotubes were exposed to DMEM supplemented with
0.24mmol/l fat free albumin (BSA), 0.5 mmol/l L-carnitine, 20 mmol/l HEPES,
[1-14C] palmitic acid (2.0 μCi/ml, 0.6 mmol/l), and 25 pmol/l or 1 μmol/l of
insulin to study basal PA oxidation. Flasks were air-tightened with stopper tops.
After 4 h, 300 μl phenyl ethylamine–methanol (1:1, v/v) were added with a
syringe to a centre well containing a folded filter paper. 300 μl 1 mol/l
perchloric acid were subsequently added to the cells through the stopper topsFig. 2. Glucose uptake in myotubes established from lean and obese and T2D subj
cultures were established from lean (open bars), obese (hatched bars) and T2D s
conditions (5.5 mmol/l glucose, 25 pmol/l insulin) and exposed to the following med
(b) basal medium supplemented with 1.0 μg/ml antimycin A (AA); and (c) basal m
supplemented with 1.0 mmol/l 2,4-dinitrophenol (DNP), and subsequently basal (ba
Methods. (A) Absolute values. *p<0.05 insulin-stim vs. corresponding basal. ^p<0
corresponding OL. cp<0.05 vs. corresponding AA. (B) Glucose uptake increment
#p<0.08 vs. lean. ap<0.05 vs. corresponding control. Data are shown as mean±SEusing a syringe. The flasks were placed for a minimum of 1 h at room
temperature to trap labeled CO2. Cell-free flasks (no-cell controls) went
through the same procedure to correct for unspecific CO2 trapping. The
incubation media were transferred into new tubes and assayed for ASM (18).
PA:BSA ratio was 2.5:1. Control and treated myotubes were exposed for equal
amount of fatty acid free BSA.
2.12. Methodological considerations
Pentose phosphate shunt: In the present study we determined glucose uptake
(GT), glucose oxidation (Gox), and the rate of GS under normophysiological
conditions and during inhibited mitochondrial oxidation. CO2 generation from
glucose is mainly explained by mitochondrial oxidation and by the activity of
the pentose phosphate shunt. By inhibiting mitochondrial oxidation we can
estimate the activity of the pentose phosphate shunt by collecting released CO2.ects after exposure to mitochondrial respiratory inhibitors. Human satellite cell
ubjects (black bars), grown and differentiated for 8 days under physiological
ia conditions for 4 h: (a) basal medium (5.5 mmol/l Glucose, 25 pmol/l Insulin);
edium supplemented with 5.0 μgm/l oligomycin (OL); and (d) basal medium
s) and insulin-stimulated (stim) glucose uptake was determined as described in
.05 vs. lean. #p<0.08 vs. lean. ap<0.05 vs. corresponding control. bp<0.05 vs.
during acute insulin stimulation expressed as fold change. ^p<0.05 vs. lean.
M. N=8.
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pathway can be determined as:
Fmet ¼ GoxðinhÞ=ðGTðinhÞ  GSðinhÞÞ ð1Þ
where (inh) indicates rates under conditions of inhibition and where GT(inh)–
GS(inh) corrects for glucose which is not available for pentose phosphate shunt
as it is mainly incorporated in glycogen.
The activity of pentose phosphate shunt:
Pentose phosphate shunt ¼ FmetðGT−GSÞ
¼ GoxðinhÞ ðGT−GSÞ=ðGTðinhÞ  GSðinhÞÞ ð2Þ
2.13. Statistical analysis
Data in text, tables, and figures are given as mean±SE. Statistical analyses
were performed with INSTAT 2.01 (GraphPad, USA). Kruskal–Wallis test orFig. 3. Glucose oxidation in myotubes established from lean and obese and T2D sub
cultures were established from lean (open bars), obese (hatched bars) and T2D subject
(5.5 mmol/l glucose, 25 pmol/l insulin) and exposed to the following media conditio
medium supplemented with 1.0 μg/ml AA; and (c) basal medium supplemented with 5
2,4-dinitrophenol (DNP), and subsequently basal (bas) and insulin stimulated (stim) g
*p<0.05 insulin-stim vs. corresponding basal. ^p<0.05 vs. lean. #p<0.08 vs. lean. ap
correspondingAA. (B) Glucose oxidation increment during acute insulin stimulation eFriedman's test with Dunn comparison test were used to assess non-paired and
paired significant differences between multiple treatments. Pearson correlation
coefficient was used for covariance analysis. p≤0.05 was considered to be
significant.3. Results
3.1. Subject characteristics
Clinical characteristics of the lean and obese controls and T2D
patients are shown in Table 1. Fasting plasma glucose, serum
insulin, and HbA1c levels were significantly higher in the
diabetic group compared with both the lean and obese controls.
Fasting HDL cholesterol concentrations were lower in T2D
patients compared with lean controls. The obese controls showedjects after exposure to mitochondrial respiratory inhibitors. Human satellite cell
s (black bars), grown and differentiated for 8 days under physiological conditions
ns for 4 h: (a) basal medium (5.5 mmol/l Glucose, 25 pmol/l Insulin); (b) basal
.0 μgm/l oligomycin (OL); and (d) basal medium, supplemented with 1.0 mmol/l
lucose oxidation was determined as described in Methods. (A) Absolute values.
<0.05 vs. corresponding control. bp<0.05 vs. corresponding OL. c p<0.05 vs.
xpressed as fold change. *p<0.05 vs. lean. Data are shown asmean±SEM.N=8.
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During the steady state of the hyperinsulinemic euglycemic
clamp period, the glucose infusion rates (GIR) were significantly
lower in T2D patients compared with both lean and obese control
subjects, and GIR were significantly lower in obese controls
compared with lean control subjects.
3.2. Cell culture
Established cultures form many myotubes as shown by phase
contrast microscope (not shown). We could not differentiate
between study groups by visual inspection. The various
treatments used in the present study proved not to be toxic for
the cells, as verified by measurements of cellular protein content
(not shown).Fig. 4. Glycogen synthesis (GS) in myotubes established from lean and obese an
satellite cell cultures were established from lean (open bars), obese (hatched bar
physiological conditions (5.5 mmol/l glucose, 25 pmol/l insulin) and exposed to the
pmol/l Insulin); (b) basal medium supplemented with 1.0 μg/ml AA; and (c) basal
supplemented with 1.0 mmol/l 2,4-dinitrophenol (DNP), and subsequently basal (bas
Absolute values. *p<0.05 insulin-stim vs. corresponding basal. ^p<0.05 vs. lean. #p
OL. cp<0.05 vs. corresponding AA. (B) GS increment during acute insulin stimu
ap<0.05 vs. corresponding control. Data are shown as mean±SEM. N=8.3.3. Glucose uptake is increased in myotubes inhibited with
OL, AA, and 2,4-Dinitrophenol (DNP), and insulin resistance
is developed in myotubes exposed to OL and AA
Diabetic myotubes expressed an increased basal glucose
uptake compared with myotubes from lean controls (p<0.05)
(Fig. 1a), while the insulin response was significantly reduced
compared with lean myotubes when precultured under normo-
physiological conditions (p<0.05) (Fig. 2B). Basal and insulin-
stimulated glucose uptake increased significantly in myotubes
of all three groups (p<0.05) when exposed to OL, AA and DNP,
mostly for the latter (Fig. 2A). The insulin response (fold change)
was significantly reduced (p<0.05) in myotubes exposed to OL
and AA, while only obese myotubes seem to respond with
reduced insulin effect during DNP inhibition (Fig. 2B).d T2D subjects after exposure to mitochondrial respiratory inhibitors. Human
s) and T2D subjects (black bars), grown and differentiated for 8 days under
following media conditions for 4 h: (a) basal medium (5.5 mmol/l Glucose, 25
medium supplemented with 5.0 μgm/l oligomycin (OL); and (d) basal medium
) and insulin-stimulated (stim) GS was determined as described in Methods. (A)
<0.08 vs. lean. ap<0.05 vs. corresponding control. bp<0.05 vs. corresponding
lation expressed as fold change. ^p<0.05 vs. lean. #p<0.08 vs. lean control.
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OL, AA and increased by DNP, but they did not induce insulin
resistance at the level of glucose oxidation
Diabetic myotubes precultured under baseline conditions
expressed an increased basal and insulin-stimulated glucose oxi-
dation compared with lean myotubes (p<0.05) (Fig. 3A), while
the insulin responsewas significantly reduced comparedwith lean
myotubes (p<0.05) (Fig. 3B). Basal and insulin-stimulated
glucose uptake decreased significantly in myotubes of all three
groups when exposed to OL and AA compared with baseline
condition (p<0.05). In contrast, DNP significantly increased
both basal and insulin-stimulated glucose oxidation (p<0.05)
(Fig. 3A). All myotubes were insulin sensitive, but OL, AA, and
DNP did not alter the insulin response significantly (Fig. 3B).
3.5. Glycogen synthesis is reduced in myotubes inhibited with
OL, AA, and DNP, while Insulin resistance was only induced in
lean myotubes
The insulin response on GS was significantly reduced in dia-
betic myotubes compared with lean myotubes precultured under
baseline conditions (Fig. 4B). Both basal and insulin-stimulated
GS were decreased significantly in myotubes of all three groups
when exposed to OL, AA, and DNP compared with baseline
condition, mostly during DNP (Fig. 4A). All myotubes were
insulin sensitive, but OL, AA, and DNP only reduced the insulin
response (fold change) significantly in lean myotubes (Fig. 4B).
3.6. Lactate production is increased in myotubes inhibited with
OL, AA, and DNP
We measured the lactate accumulation in the media of
myotubes exposed to baseline conditions and various inhibitors.Fig. 5. Lactate production in myotubes established from lean and obese and T2D sub
cultures were established from lean (open bars), obese (hatched bars) and T2D s
conditions (5.5 mmol/l glucose, 25 pmol/l insulin) and exposed to the following med
(b) basal medium supplemented with 1.0 μg/ml AA; and (c) basal medium suppleme
1.0 mmol/l 2,4-dinitrophenol (DNP), and subsequently basal (bas) and insulin-stimul
values. *p< 0.05 insulin-stim vs. corresponding basal. ^p<0.05 vs. lean. #p<0.08 vs.Lactate production was increased in obese and diabetic
myotubes precultured under baseline conditions. Both basal
and insulin-mediated lactate production was significantly
increased in all three groups when exposed to OL, AA, and
DNP. Significant differences between groups were only detected
at the basal level of DNP exposure (Fig. 5).
3.7. The insulin response on PA uptake in human myotubes is
reduced by OL, AA, and DNP
We studied the effect of oligomycin A (OL), AA, and DNP
inhibition on basal and acute insulin-stimulated PA uptake in
myotubes established from lean, obese, and T2D subjects (Figs.
6A, B). Basal and insulin-stimulated PA uptake was not
significantly different between groups (p>0.40). PA uptake
was insulin sensitive in all myotubes (p<0.05). Exposure to OL,
AA or DNP did not significantly change basal or insulin-
stimulated PA uptake (Fig. 7A). However, all inhibitors
decreased the insulin response (fold change) in lean, obese,
and diabetic myotubes (Fig. 7B).
3.8. PA oxidation is reduced in myotubes inhibited with OL, AA
while increased by DNP
PA oxidation was not significantly different between groups
in the present study under various experimental conditions,
although diabetic and obese myotubes PA oxidation tended
to be lower. Myotubes exposed to OL and AA expressed a
reduced ASM and complete PA oxidation compared with
baseline conditions, mostly pronounced for AA (Fig. 7A). The
complete oxidation is reduced to 11% of baseline by AA and
to 21% by OL. ASM is reduced to 65% and 47% of baseline
by OL and AA, respectively. In contrast DNP increased PA
oxidation in all myotubes based on a significant increase of thejects after exposure to mitochondrial respiratory inhibitors. Human satellite cell
ubjects (black bars), grown and differentiated for 8 days under physiological
ia conditions for 4 h: (a) basal medium (5.5 mmol/l Glucose, 25 pmol/l Insulin);
nted with 5.0 μgm/l oligomycin (OL); and (d) basal medium supplemented with
ated (stim) lactate production was determined as described in Methods. Absolute
lean. ap<0.05 vs. corresponding control. Data are shown as mean±SEM. N=8.
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increased by a factor of 3.2 by DNP, while beta oxidation was
reduced to 75% of baseline level. Overall, the PA oxidation
was reduced to 51% by OL and to 36% by AA, while DNP
increased PA oxidation by 50% compared with baseline level.
A measurement of the oxidation in peroxisomes can be
obtained under studies blocking mitochondrial oxidation. No
significant differences in the fractional distribution of PA
between peroxisomes and mitochondrial were detected
between groups (data not shown).
3.9. The activity of the pentose phosphate shunt is insulin
sensitive and increased in diabetic myotubes
Based on the above data it is possible to calculate the activity
of the pentose phosphate shunt in myotubes as described underFig. 6. PA uptake in myotubes established from lean and obese and T2D subjects aft
were established from lean (open bars), obese (hatched bars) and T2D subjects (b
(5.5 mmol/l glucose, 25 pmol/l insulin) and exposed to the following media conditio
medium supplemented with 1.0 μg/ml AA; and (c) basal medium supplemented with 5
2,4-dinitrophenol (DNP), and subsequently basal (bas) and insulin-stimulated (stim
*p<0.05 insulin-stim vs. corresponding basal. ^p<0.05 vs. lean. ap<0.05 vs. corresp
(B) PA uptake increment during acute insulin stimulation expressed as fold change. ap
as mean±SEM. N=8.metabolic considerations. The activity of the pentose phosphate
shunt was insulin sensitive in all myotubes and was signifi-
cantly increased both at basal level and during insulin sti-
mulation in diabetic myotubes compared with lean myotubes
(Fig. 8A). The difference between groups was still present when
correcting for differences in glucose uptake (Fig. 8B), while the
insulin effect seems based on an increased glucose uptake.
4. Discussion
The impetus for this study was the paradigm that
mitochondrial dysfunction is associated with insulin resistance
in obese and T2D subjects. Glucose and lipid metabolism were
studied in human myotubes established from lean, obese, and
T2D subjects during exposure to AA, OL, and DNP in order to
reduce ATP production from oxidative phosphorylation, eitherer exposure to mitochondrial respiratory inhibitors. Human satellite cell cultures
lack bars), grown and differentiated for 8 days under physiological conditions
ns for 4 h: (a) basal medium (5.5 mmol/l Glucose, 25 pmol/l Insulin); (b) basal
.0 μgm/l oligomycin (OL); and (d) basal medium supplemented with 1.0 mmol/l
) PA uptake was determined as described in Methods. (A) Absolute values.
onding control. bp<0.05 vs. corresponding OL. cp<0.05 vs. corresponding AA.
<0.05 vs. corresponding control. bp<0.05 vs. corresponding OL. Data are shown
Fig. 7. PA oxidation in myotubes established from lean and obese and T2D subjects after exposure to mitochondrial respiratory inhibitors. Human satellite cell cultures
were established from lean (open bars), obese (hatched bars) and T2D subjects (black bars), grown and differentiated for 8 days under physiological conditions
(5.5 mmol/l glucose, 25 pmol/l insulin) and exposed to the following media conditions for 4 h: (a) basal medium (5.5 mmol/l Glucose, 25 pmol/l Insulin); (b) basal
medium supplemented with 1.0 μg/ml AA; and (c) basal medium supplemented with 5.0 μgm/l oligomycin (OL); and (d) basal medium supplemented with 1.0 mmol/l
2,4-dinitrophenol (DNP), and subsequently basal PA oxidation was determined as described in Methods. Absolute values: ASM, acid soluble metabolites, CO2,
complete oxidation and total oxidation are the sum of ASM and CO2.
ap<0.05 vs. corresponding control. bp<0.05 vs. corresponding OL. cp<0.05 vs. corresponding
AA. Data are shown as mean±SEM. N=8.
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chain or indirectly by disturbing the proton gradient across the
mitochondrial membrane by the ionophor DNP. Experiments
were done under normoglycemic conditions, in order to ensure
substrates for ATP production from glycolysis. The advantages
of using human myotubes are that the extracellular environ-
ment can be controlled precisely and kept constant over time,
thus allowing us to study the importance of the genetic back-
ground or single exogenous factors without systemic, homeo-
static regulatory components from the nervous and endocrine
systems.
Direct inhibition of the electron transport chain or the ATP
synthase was followed by increased glucose uptake and lactate
production, reduced glycogen synthesis, reduced lipid and
glucose oxidation and unchanged lipid uptake, thus changing the
glucose metabolism in the direction of anaerobe metabolism
with only minimal changes in lipid metabolism. Glucose
metabolism still allows ATP production in the absence of
oxygen through oxidation of glucose to pyruvate and the
conversion of pyruvate to lactate. In contrast, fatty acids cannot
be completely oxidized by other organelles than mitochondria,
although the beta oxidation in peroxisomes may partly
metabolize fatty acids. Lipid and glucose oxidation was reduced
in accordance with the mode of action of these inhibitors.
Indirect inhibition of mitochondrial ATP production expresses
the same picture, except for an increase in glucose and PA
oxidation during uncoupling.
Antimycin A and oligomycin treatment was followed by
insulin resistance at the level of glucose and PA uptake in all
three study groups, while glycogen synthesis was only affected
in lean myotubes, suggesting that impaired mitochondrial
function has a role in the pathophysiology of insulin resistance.
The present study is the first convincing data linking functionalmitochondrial impairment per se and insulin resistance. Rabøl
et al. [19] have very recently reviewed mitochondrial oxidative
function and type 2 diabetes and concluded, that the reduced
oxidative capacity in most studies are explained by decreased
mitochondrial content. We have previously tried to verify a
reduced mitochondrial content in diabetic myotubes by three
different parameters, but showed no significant differences in
mitochondrial content between groups [10]. Although a
reduced mitochondrial content not could be verified in diabetic
myotubes imply our findings, that also a reduced mitochon-
drial content is linked to insulin resistance, supporting previous
in vivo studies describing an association between reduced
mitochondrial content and insulin resistance (reviewed
[19,2,20]). Further studies have to clarify the magnitude of
reduction in mitochondrial content necessary for or the degree
of functional impairment, which can induce insulin resistance.
Both the mitochondrial oxidative capacity and insulin
sensitivity of skeletal muscle are highly influenced by physical
activity, ageing, and fiber type composition, rendering it
difficult to clarify whether a direct link exists between mito-
chondrial dysfunction and insulin resistance in T2D. Cultures
of human myotubes are not influenced by these parameters, as
myotubes in culture all express fast heavy myosin, seldom
contract spontaneous [14] and in the present study are
established from subjects at comparable age and used in the
same passage. The diabetic phenotype was conserved in
diabetic myotubes, as verified by a reduced, insulin-stimulated
increment in glucose uptake, glucose oxidation, and glycogen
synthesis. The question arises whether the mitochondria in
diabetic myotubes already express functional mitochondrial
defects. The insulin resistance in diabetic myotubes could be
worsened by the metabolic inhibitors, indicating that possible
defects in the mitochondria in diabetic myotubes are only
Fig. 8. Activity of the pentose phosphate shunt in myotubes established from
lean and obese and T2D subjects. Human satellite cell cultures were established
from lean, obese and T2D subjects, grown and differentiated for 8 days under
physiological conditions (5.5 mmol/l glucose, 25 pmol/l insulin) and the pentose
phosphate shunt actvity was determined as described in Methods. (A) Basal
(open bars) and insulin-stimulated rates of the pentose phosphate shunt (black
bars). *p<0.05 Insulin-stim vs. corresponding basal. ap<0.05 vs. lean. (B)
Activity rates of the pentose phosphate shunt corrected for glucose uptake.
ap<0.05 vs. lean. Data are shown as mean±SEM. N=8.
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express a 14% reduction in basal activity of citrate synthase
compared to lean myotubes, implying a mild mitochondrial
impairment [10]. Increased accumulation of intracellular
triglyceride (TAG) has been associated with insulin resistance
and linked to mitochondrial dysfunction [1,2,21–27]. We have
recently shown that induced inhibition of oxidative phosphor-
ylation by AA and OA was followed by TAG accumulation
[28]. Thus above myotubes studies indicate, that induced
mitochondrial impairment is linked both to TAG accumulation
and insulin resistance. Taken together functional mitochondrial
impairment could be part of the pathophysiology of insulin
resistance and TAG accumulation in vivo.
In the present study, a new finding is that the activity of the
pentose phosphate shunt was increased twice in diabetic
myotubes compared with lean myotubes. The shunt activity
seems insulin sensitive, but this effect disappeared when
corrected for changes in the insulin-mediated glucose uptake.
The pentose phosphate shunt metabolizes 2% of glucose taken
up for glycolysis in human myotubes, which is in line with
previous in vitro and in vivo studies. The major function of thepentose phosphate shunt is to provide NADPH for reductive
synthesis of fatty acids and amino acids outside the
mitochondria and to provide ribose for nucleotide and nucleic
acids. It could be speculated whether the increased activity of
the pentose phosphate shunt may contribute to the increased
triacylglycereol content seen in obese and T2D patients.
Further studies are needed to test this hypothesis. The pathway
has not been shown to participate directly in the pathogenesis
of insulin resistance.
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